Brief: Theravance Biopharma Q2 Operating Income USD -2.725 Million
12/08/2025 21:05
Aug 12 (Reuters) - Theravance Biopharma Q2 revenue USD 7.5 million vs. IBES estimate USD 26 million. Q2 net income USD 54.835 million Q2 adjusted net income USD -4.225 million vs. IBES estimate USD -12.3 million Q2 EPS USD 1.08
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions